Zejing Pharmaceuticals (688266.SH) submitted an application for the issuance and listing of H shares on the Hong Kong Stock Exchange and published the application materials.
Zejing Pharmaceutical (688266.SH) announced that on December 19, 2025, the company submitted an application to the Stock Exchange of Hong Kong (HKEX) for the issuance of H shares and listing on the main board of HKEX. On the same day, the company published the application materials on the HKEX website. The application materials were prepared and published in accordance with the requirements of the Hong Kong Securities and Futures Commission (SFC) and HKEX, and are draft versions. The information contained in the materials may be updated and revised in a timely manner, and investors should not make any investment decisions based on the information provided.
Zejing Pharmaceuticals (688266.SH) announced that on December 19, 2025, the company submitted an application to the Hong Kong Stock Exchange to issue H shares and list them on the Main Board of the Hong Kong Stock Exchange. On the same day, the application materials for this issuance were published on the Hong Kong Stock Exchange website. The application materials were prepared and published in accordance with the requirements of the Securities and Futures Commission of Hong Kong (referred to as the "Hong Kong Securities and Futures Commission") and the Hong Kong Stock Exchange, and are draft versions. The information contained therein may be updated and revised in a timely manner, and investors should not make any investment decisions based on the information therein.
Related Articles
China Kings Resources Group (603505.SH) intends to purchase 15.71% equity of Noah Fluorine Chemicals Co., Ltd. for 257 million yuan, becoming its second largest shareholder.
Ackman throws out new listing plan for SpaceX: No traditional IPO, no underwriting fees. Shareholders of Tesla, Inc. (TSLA.US) can get in first.
Nanhua Futures (603093.SH) Overseas subsidiary has obtained relevant membership qualifications.
China Kings Resources Group (603505.SH) intends to purchase 15.71% equity of Noah Fluorine Chemicals Co., Ltd. for 257 million yuan, becoming its second largest shareholder.
Ackman throws out new listing plan for SpaceX: No traditional IPO, no underwriting fees. Shareholders of Tesla, Inc. (TSLA.US) can get in first.
Nanhua Futures (603093.SH) Overseas subsidiary has obtained relevant membership qualifications.
